Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.545 SGD | +0.93% | 0.00% | -1.80% |
03-15 | Chemical Industries Far East Appoints Acting CEO | MT |
03-14 | Chemical Industries (Far East) Limited Announces Chief Executive Office Changes | CI |
Valuation
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 56.2 | 55.44 | 48.98 | 52.4 | 57.72 | 53.16 |
Enterprise Value (EV) 1 | 32.96 | 23.29 | 23.61 | 16.19 | 17.43 | 27.31 |
P/E ratio | 6.08 x | 5.19 x | 14.6 x | 9.41 x | 8.49 x | 15 x |
Yield | 2.03% | 2.05% | 2.33% | 2.17% | 1.97% | 2.14% |
Capitalization / Revenue | 0.79 x | 0.81 x | 0.79 x | 0.83 x | 0.68 x | 0.53 x |
EV / Revenue | 0.47 x | 0.34 x | 0.38 x | 0.26 x | 0.21 x | 0.27 x |
EV / EBITDA | 3.16 x | 2.42 x | 2.51 x | 1.74 x | 1.23 x | 13.4 x |
EV / FCF | -61.6 x | 1.99 x | 1,968 x | 2.39 x | 42.9 x | -3.22 x |
FCF Yield | -1.62% | 50.3% | 0.05% | 41.9% | 2.33% | -31% |
Price to Book | 0.52 x | 0.47 x | 0.41 x | 0.42 x | 0.44 x | 0.4 x |
Nbr of stocks (in thousands) | 75,945 | 75,945 | 75,945 | 75,945 | 75,945 | 75,945 |
Reference price 2 | 0.7400 | 0.7300 | 0.6450 | 0.6900 | 0.7600 | 0.7000 |
Announcement Date | 6/13/18 | 6/11/19 | 7/27/20 | 7/1/21 | 7/4/22 | 7/10/23 |
Income Statement Evolution (Annual data)
Fiscal Period: Marzo | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 70.86 | 68.82 | 62.22 | 63 | 85 | 100 |
EBITDA 1 | 10.43 | 9.635 | 9.418 | 9.317 | 14.23 | 2.044 |
EBIT 1 | 3.901 | 3.05 | 4.679 | 4.796 | 9.132 | -2.737 |
Operating Margin | 5.51% | 4.43% | 7.52% | 7.61% | 10.74% | -2.74% |
Earnings before Tax (EBT) 1 | 9.77 | 11.37 | 4.47 | 6.844 | 5.811 | 4.066 |
Net income 1 | 9.241 | 10.69 | 3.356 | 5.57 | 6.8 | 3.554 |
Net margin | 13.04% | 15.53% | 5.39% | 8.84% | 8% | 3.55% |
EPS 2 | 0.1217 | 0.1407 | 0.0442 | 0.0733 | 0.0895 | 0.0468 |
Free Cash Flow 1 | -0.5348 | 11.72 | 0.012 | 6.778 | 0.4062 | -8.472 |
FCF margin | -0.75% | 17.03% | 0.02% | 10.76% | 0.48% | -8.47% |
FCF Conversion (EBITDA) | - | 121.6% | 0.13% | 72.74% | 2.85% | - |
FCF Conversion (Net income) | - | 109.61% | 0.36% | 121.68% | 5.97% | - |
Dividend per Share 2 | 0.0150 | 0.0150 | 0.0150 | 0.0150 | 0.0150 | 0.0150 |
Announcement Date | 6/13/18 | 6/11/19 | 7/27/20 | 7/1/21 | 7/4/22 | 7/10/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 23.2 | 32.2 | 25.4 | 36.2 | 40.3 | 25.9 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | -0.53 | 11.7 | 0.01 | 6.78 | 0.41 | -8.47 |
ROE (net income / shareholders' equity) | 8.8% | 9.43% | 2.81% | 4.54% | 5.33% | 2.71% |
ROA (Net income/ Total Assets) | 2.07% | 1.53% | 2.16% | 2.1% | 3.83% | -1.15% |
Assets 1 | 445.5 | 700.4 | 155.4 | 265.5 | 177.6 | -310.2 |
Book Value Per Share 2 | 1.430 | 1.560 | 1.590 | 1.640 | 1.720 | 1.730 |
Cash Flow per Share 2 | 0.3100 | 0.4200 | 0.4200 | 0.5500 | 0.5900 | 0.3900 |
Capex 1 | 1.4 | 2.82 | 9.69 | 2.77 | 1.85 | 5.76 |
Capex / Sales | 1.98% | 4.09% | 15.58% | 4.4% | 2.18% | 5.75% |
Announcement Date | 6/13/18 | 6/11/19 | 7/27/20 | 7/1/21 | 7/4/22 | 7/10/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-1.80% | 30.67M | |
+3.47% | 103B | |
-8.02% | 61.43B | |
+72.86% | 49.09B | |
+15.48% | 38.46B | |
+3.64% | 32.09B | |
+13.29% | 20.39B | |
+12.53% | 16.78B | |
+15.34% | 14.76B | |
+0.39% | 13.73B |
- Stock Market
- Equities
- C05 Stock
- Financials Chemical Industries (Far East) Limited